Dr. Noelia Ferruz has begun work to build ATHENA, a new AI model which can create proteins with custom properties that do not exist in nature.
Researchers dicover 813 potential new cancer therapeutic targets when taking splicing into account
Technology paves the way for new diagnostic and monitoring strategies
The tool can accelerate the design of clinical trials for drugs that target single-mutation diseases
The findings can boost efforts in medical research, drug testing, and regenerative therapies.
Research with preclinical models suggest this could be reversed with HIV medication lamivudine
Dr. Ferruz has joined the CRG to develop protein language models that can tackle global challenges
